This newslink doesn't exist or it was removed.
Go to Homempage.
CBS News USA Politics April 28, 2023
A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after promising early results suggested it may work against all known variants of... + más
FDA withdraws emergency use authorization of COVID drug because it is unlikely to be effective against new variants | ABC News
FDA pulls authorization for AstraZeneca’s Covid antibody drug Evusheld | NBC News
ABC7 USA Health October 24, 2023
is reviewing an application for the nasal spray vaccine FluMist to be able to be self-administered at home, drugmaker AstraZeneca said Tuesday.The vaccine, the only nasal spray option against flu, has been on the market in the United States since 2003. AstraZeneca has asked the... + más
When is the best time to get a flu shot? And what kind should I get? | Los Angeles Times
Flu shot myths make us sick — experts bust 6 of the major ones | New York Post
The Boston Globe USA Business June 14, 2023
ENERGYAstraZeneca signs deal with Waltham-based firm for renewable natural gasVanguard Renewables has signed a contract with drug giant AstraZeneca to deliver renewable natural gas to all of AstraZeneca’s 12 sites in the United States. Waltham-based Vanguard is developing... + más
High school scores and top performers from Friday, March 24 | Orlando Sentinel
High school scores and top performers from Thursday, March 9 | Orlando Sentinel
RTTNews USA Health December 04, 2023
Absci () announced a collaboration with AstraZeneca to deliver an AI-designed antibody against an oncology target. Absci will contribute its generative AI to deliver a therapeutic candidate antibody for a specified oncology target. The deal includes an upfront commitment, R&D... + más
AstraZeneca says new COVID drug could guard against all variants of concern to date | CBS News
FDA reviewing application for 1st flu vaccine that could be self-administered at home | ABC7
ABC News USA Health November 04, 2022
In what could signal the promise of progress to come for newborn infants at risk for RSV, a new monoclonal antibody is being granted approval in Europe as a preventative measure to protect against RSV infection in very young babies -- those most at risk of contracting the virus... + más
Pfizer says study shows vaccinating pregnant women protects newborns from RSV | ABC7
Strong RSV vaccine data lifts hopes after years of futility | 10 WBNS
About iurex | Privacy Policy | Disclaimer |